Personal CFO Solutions’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $321K | Buy |
3,679
+233
| +7% | +$20.3K | 0.06% | 311 |
|
2025
Q1 | $235K | Buy |
3,446
+234
| +7% | +$16K | 0.05% | 384 |
|
2024
Q4 | $250K | Buy |
+3,212
| New | +$250K | 0.05% | 380 |
|
2024
Q3 | – | Sell |
-3,552
| Closed | -$403K | – | 570 |
|
2024
Q2 | $403K | Sell |
3,552
-3
| -0.1% | -$340 | 0.06% | 300 |
|
2024
Q1 | $493K | Buy |
3,555
+7
| +0.2% | +$971 | 0.08% | 254 |
|
2023
Q4 | $440K | Buy |
3,548
+218
| +7% | +$27.1K | 0.08% | 262 |
|
2023
Q3 | $311K | Buy |
3,330
+366
| +12% | +$34.1K | 0.06% | 312 |
|
2023
Q2 | $381K | Buy |
2,964
+98
| +3% | +$12.6K | 0.08% | 271 |
|
2023
Q1 | $333K | Buy |
2,866
+81
| +3% | +$9.41K | 0.07% | 278 |
|
2022
Q4 | $315K | Sell |
2,785
-107
| -4% | -$12.1K | 0.07% | 278 |
|
2022
Q3 | $233K | Sell |
2,892
-29
| -1% | -$2.34K | 0.06% | 321 |
|
2022
Q2 | $218K | Sell |
2,921
-67
| -2% | -$5K | 0.05% | 368 |
|
2022
Q1 | $382K | Sell |
2,988
-68
| -2% | -$8.69K | 0.08% | 252 |
|
2021
Q4 | $410K | Buy |
3,056
+124
| +4% | +$16.6K | 0.08% | 233 |
|
2021
Q3 | $401K | Buy |
2,932
+216
| +8% | +$29.5K | 0.08% | 220 |
|
2021
Q2 | $290K | Buy |
2,716
+264
| +11% | +$28.2K | 0.06% | 295 |
|
2021
Q1 | $220K | Buy |
+2,452
| New | +$220K | 0.05% | 361 |
|